Global Dementia and Alzheimer’s Disease Treatment Market Size, Status and Forecast 2024-2031

Report ID: 922377 | Published Date: Sep 2024 | No. of Page: 108 | Base Year: 2023 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Dementia and Alzheimer’s Disease Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Cholinesterase Inhibitors
        1.2.3 Memantine
        1.2.4 Combination Drugs
    1.3 Market by Application
        1.3.1 Global Dementia and Alzheimer’s Disease Treatment Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospital
        1.3.3 Clinic
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Dementia and Alzheimer’s Disease Treatment Market Perspective (2016-2027)
    2.2 Dementia and Alzheimer’s Disease Treatment Growth Trends by Regions
        2.2.1 Dementia and Alzheimer’s Disease Treatment Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Dementia and Alzheimer’s Disease Treatment Historic Market Share by Regions (2016-2021)
        2.2.3 Dementia and Alzheimer’s Disease Treatment Forecasted Market Size by Regions (2022-2027)
    2.3 Dementia and Alzheimer’s Disease Treatment Industry Dynamic
        2.3.1 Dementia and Alzheimer’s Disease Treatment Market Trends
        2.3.2 Dementia and Alzheimer’s Disease Treatment Market Drivers
        2.3.3 Dementia and Alzheimer’s Disease Treatment Market Challenges
        2.3.4 Dementia and Alzheimer’s Disease Treatment Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Dementia and Alzheimer’s Disease Treatment Players by Revenue
        3.1.1 Global Top Dementia and Alzheimer’s Disease Treatment Players by Revenue (2016-2021)
        3.1.2 Global Dementia and Alzheimer’s Disease Treatment Revenue Market Share by Players (2016-2021)
    3.2 Global Dementia and Alzheimer’s Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Dementia and Alzheimer’s Disease Treatment Revenue
    3.4 Global Dementia and Alzheimer’s Disease Treatment Market Concentration Ratio
        3.4.1 Global Dementia and Alzheimer’s Disease Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Dementia and Alzheimer’s Disease Treatment Revenue in 2020
    3.5 Dementia and Alzheimer’s Disease Treatment Key Players Head office and Area Served
    3.6 Key Players Dementia and Alzheimer’s Disease Treatment Product Solution and Service
    3.7 Date of Enter into Dementia and Alzheimer’s Disease Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Dementia and Alzheimer’s Disease Treatment Breakdown Data by Type
    4.1 Global Dementia and Alzheimer’s Disease Treatment Historic Market Size by Type (2016-2021)
    4.2 Global Dementia and Alzheimer’s Disease Treatment Forecasted Market Size by Type (2022-2027)

5 Dementia and Alzheimer’s Disease Treatment Breakdown Data by Application
    5.1 Global Dementia and Alzheimer’s Disease Treatment Historic Market Size by Application (2016-2021)
    5.2 Global Dementia and Alzheimer’s Disease Treatment Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Dementia and Alzheimer’s Disease Treatment Market Size (2016-2027)
    6.2 North America Dementia and Alzheimer’s Disease Treatment Market Size by Type
        6.2.1 North America Dementia and Alzheimer’s Disease Treatment Market Size by Type (2016-2021)
        6.2.2 North America Dementia and Alzheimer’s Disease Treatment Market Size by Type (2022-2027)
        6.2.3 North America Dementia and Alzheimer’s Disease Treatment Market Size by Type (2016-2027)
    6.3 North America Dementia and Alzheimer’s Disease Treatment Market Size by Application
        6.3.1 North America Dementia and Alzheimer’s Disease Treatment Market Size by Application (2016-2021)
        6.3.2 North America Dementia and Alzheimer’s Disease Treatment Market Size by Application (2022-2027)
        6.3.3 North America Dementia and Alzheimer’s Disease Treatment Market Size by Application (2016-2027)
    6.4 North America Dementia and Alzheimer’s Disease Treatment Market Size by Country
        6.4.1 North America Dementia and Alzheimer’s Disease Treatment Market Size by Country (2016-2021)
        6.4.2 North America Dementia and Alzheimer’s Disease Treatment Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Dementia and Alzheimer’s Disease Treatment Market Size (2016-2027)
    7.2 Europe Dementia and Alzheimer’s Disease Treatment Market Size by Type
        7.2.1 Europe Dementia and Alzheimer’s Disease Treatment Market Size by Type (2016-2021)
        7.2.2 Europe Dementia and Alzheimer’s Disease Treatment Market Size by Type (2022-2027)
        7.2.3 Europe Dementia and Alzheimer’s Disease Treatment Market Size by Type (2016-2027)
    7.3 Europe Dementia and Alzheimer’s Disease Treatment Market Size by Application
        7.3.1 Europe Dementia and Alzheimer’s Disease Treatment Market Size by Application (2016-2021)
        7.3.2 Europe Dementia and Alzheimer’s Disease Treatment Market Size by Application (2022-2027)
        7.3.3 Europe Dementia and Alzheimer’s Disease Treatment Market Size by Application (2016-2027)
    7.4 Europe Dementia and Alzheimer’s Disease Treatment Market Size by Country
        7.4.1 Europe Dementia and Alzheimer’s Disease Treatment Market Size by Country (2016-2021)
        7.4.2 Europe Dementia and Alzheimer’s Disease Treatment Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Size (2016-2027)
    8.2 Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Size by Type
        8.2.1 Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Size by Type (2016-2027)
    8.3 Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Size by Application
        8.3.1 Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Size by Application (2016-2027)
    8.4 Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Size by Region
        8.4.1 Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Dementia and Alzheimer’s Disease Treatment Market Size (2016-2027)
    9.2 Latin America Dementia and Alzheimer’s Disease Treatment Market Size by Type
        9.2.1 Latin America Dementia and Alzheimer’s Disease Treatment Market Size by Type (2016-2021)
        9.2.2 Latin America Dementia and Alzheimer’s Disease Treatment Market Size by Type (2022-2027)
        9.2.3 Latin America Dementia and Alzheimer’s Disease Treatment Market Size by Type (2016-2027)
    9.3 Latin America Dementia and Alzheimer’s Disease Treatment Market Size by Application
        9.3.1 Latin America Dementia and Alzheimer’s Disease Treatment Market Size by Application (2016-2021)
        9.3.2 Latin America Dementia and Alzheimer’s Disease Treatment Market Size by Application (2022-2027)
        9.3.3 Latin America Dementia and Alzheimer’s Disease Treatment Market Size by Application (2016-2027)
    9.4 Latin America Dementia and Alzheimer’s Disease Treatment Market Size by Country
        9.4.1 Latin America Dementia and Alzheimer’s Disease Treatment Market Size by Country (2016-2021)
        9.4.2 Latin America Dementia and Alzheimer’s Disease Treatment Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size (2016-2027)
    10.2 Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size by Type
        10.2.1 Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size by Type (2016-2027)
    10.3 Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size by Application
        10.3.1 Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size by Application (2016-2027)
    10.4 Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size by Country
        10.4.1 Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Novartis
        11.1.1 Novartis Company Details
        11.1.2 Novartis Business Overview
        11.1.3 Novartis Dementia and Alzheimer’s Disease Treatment Introduction
        11.1.4 Novartis Revenue in Dementia and Alzheimer’s Disease Treatment Business (2016-2021)
        11.1.5 Novartis Recent Development
    11.2 Pfizer, Inc.
        11.2.1 Pfizer, Inc. Company Details
        11.2.2 Pfizer, Inc. Business Overview
        11.2.3 Pfizer, Inc. Dementia and Alzheimer’s Disease Treatment Introduction
        11.2.4 Pfizer, Inc. Revenue in Dementia and Alzheimer’s Disease Treatment Business (2016-2021)
        11.2.5 Pfizer, Inc. Recent Development
    11.3 AbbVie Inc.
        11.3.1 AbbVie Inc. Company Details
        11.3.2 AbbVie Inc. Business Overview
        11.3.3 AbbVie Inc. Dementia and Alzheimer’s Disease Treatment Introduction
        11.3.4 AbbVie Inc. Revenue in Dementia and Alzheimer’s Disease Treatment Business (2016-2021)
        11.3.5 AbbVie Inc. Recent Development
    11.4 Allergan plc
        11.4.1 Allergan plc Company Details
        11.4.2 Allergan plc Business Overview
        11.4.3 Allergan plc Dementia and Alzheimer’s Disease Treatment Introduction
        11.4.4 Allergan plc Revenue in Dementia and Alzheimer’s Disease Treatment Business (2016-2021)
        11.4.5 Allergan plc Recent Development
    11.5 Eli Lilly and Company
        11.5.1 Eli Lilly and Company Company Details
        11.5.2 Eli Lilly and Company Business Overview
        11.5.3 Eli Lilly and Company Dementia and Alzheimer’s Disease Treatment Introduction
        11.5.4 Eli Lilly and Company Revenue in Dementia and Alzheimer’s Disease Treatment Business (2016-2021)
        11.5.5 Eli Lilly and Company Recent Development
    11.6 F. Hoffmann-La Roche Ltd.
        11.6.1 F. Hoffmann-La Roche Ltd. Company Details
        11.6.2 F. Hoffmann-La Roche Ltd. Business Overview
        11.6.3 F. Hoffmann-La Roche Ltd. Dementia and Alzheimer’s Disease Treatment Introduction
        11.6.4 F. Hoffmann-La Roche Ltd. Revenue in Dementia and Alzheimer’s Disease Treatment Business (2016-2021)
        11.6.5 F. Hoffmann-La Roche Ltd. Recent Development
    11.7 AstraZeneca
        11.7.1 AstraZeneca Company Details
        11.7.2 AstraZeneca Business Overview
        11.7.3 AstraZeneca Dementia and Alzheimer’s Disease Treatment Introduction
        11.7.4 AstraZeneca Revenue in Dementia and Alzheimer’s Disease Treatment Business (2016-2021)
        11.7.5 AstraZeneca Recent Development
    11.8 Biogen
        11.8.1 Biogen Company Details
        11.8.2 Biogen Business Overview
        11.8.3 Biogen Dementia and Alzheimer’s Disease Treatment Introduction
        11.8.4 Biogen Revenue in Dementia and Alzheimer’s Disease Treatment Business (2016-2021)
        11.8.5 Biogen Recent Development
    11.9 Eisai Co., Ltd.
        11.9.1 Eisai Co., Ltd. Company Details
        11.9.2 Eisai Co., Ltd. Business Overview
        11.9.3 Eisai Co., Ltd. Dementia and Alzheimer’s Disease Treatment Introduction
        11.9.4 Eisai Co., Ltd. Revenue in Dementia and Alzheimer’s Disease Treatment Business (2016-2021)
        11.9.5 Eisai Co., Ltd. Recent Development
    11.10 INmuneBIO
        11.10.1 INmuneBIO Company Details
        11.10.2 INmuneBIO Business Overview
        11.10.3 INmuneBIO Dementia and Alzheimer’s Disease Treatment Introduction
        11.10.4 INmuneBIO Revenue in Dementia and Alzheimer’s Disease Treatment Business (2016-2021)
        11.10.5 INmuneBIO Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Dementia and Alzheimer’s Disease Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Cholinesterase Inhibitors
    Table 3. Key Players of Memantine
    Table 4. Key Players of Combination Drugs
    Table 5. Global Dementia and Alzheimer’s Disease Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Dementia and Alzheimer’s Disease Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Dementia and Alzheimer’s Disease Treatment Market Size by Regions (2016-2021) & (US$ Million)
    Table 8. Global Dementia and Alzheimer’s Disease Treatment Market Share by Regions (2016-2021)
    Table 9. Global Dementia and Alzheimer’s Disease Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 10. Global Dementia and Alzheimer’s Disease Treatment Market Share by Regions (2022-2027)
    Table 11. Dementia and Alzheimer’s Disease Treatment Market Trends
    Table 12. Dementia and Alzheimer’s Disease Treatment Market Drivers
    Table 13. Dementia and Alzheimer’s Disease Treatment Market Challenges
    Table 14. Dementia and Alzheimer’s Disease Treatment Market Restraints
    Table 15. Global Dementia and Alzheimer’s Disease Treatment Revenue by Players (2016-2021) & (US$ Million)
    Table 16. Global Dementia and Alzheimer’s Disease Treatment Market Share by Players (2016-2021)
    Table 17. Global Top Dementia and Alzheimer’s Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dementia and Alzheimer’s Disease Treatment as of 2020)
    Table 18. Ranking of Global Top Dementia and Alzheimer’s Disease Treatment Companies by Revenue (US$ Million) in 2020
    Table 19. Global 5 Largest Players Market Share by Dementia and Alzheimer’s Disease Treatment Revenue (CR5 and HHI) & (2016-2021)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Dementia and Alzheimer’s Disease Treatment Product Solution and Service
    Table 22. Date of Enter into Dementia and Alzheimer’s Disease Treatment Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Dementia and Alzheimer’s Disease Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 25. Global Dementia and Alzheimer’s Disease Treatment Revenue Market Share by Type (2016-2021)
    Table 26. Global Dementia and Alzheimer’s Disease Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 27. Global Dementia and Alzheimer’s Disease Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 28. Global Dementia and Alzheimer’s Disease Treatment Market Size Share by Application (2016-2021) & (US$ Million)
    Table 29. Global Dementia and Alzheimer’s Disease Treatment Revenue Market Share by Application (2016-2021)
    Table 30. Global Dementia and Alzheimer’s Disease Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 31. Global Dementia and Alzheimer’s Disease Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 32. North America Dementia and Alzheimer’s Disease Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 33. North America Dementia and Alzheimer’s Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 34. North America Dementia and Alzheimer’s Disease Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 35. North America Dementia and Alzheimer’s Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 36. North America Dementia and Alzheimer’s Disease Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 37. North America Dementia and Alzheimer’s Disease Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 38. Europe Dementia and Alzheimer’s Disease Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 39. Europe Dementia and Alzheimer’s Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 40. Europe Dementia and Alzheimer’s Disease Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 41. Europe Dementia and Alzheimer’s Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 42. Europe Dementia and Alzheimer’s Disease Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 43. Europe Dementia and Alzheimer’s Disease Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 44. Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 45. Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 46. Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Size by Region (2016-2021) & (US$ Million) 
    Table 49. Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Size by Region (2022-2027) & (US$ Million) 
    Table 50. Latin America Dementia and Alzheimer’s Disease Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 51. Latin America Dementia and Alzheimer’s Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 52. Latin America Dementia and Alzheimer’s Disease Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 53. Latin America Dementia and Alzheimer’s Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 54. Latin America Dementia and Alzheimer’s Disease Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 55. Latin America Dementia and Alzheimer’s Disease Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 56. Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 57. Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 58. Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 61. Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 62. Novartis Company Details
    Table 63. Novartis Business Overview
    Table 64. Novartis Dementia and Alzheimer’s Disease Treatment Product
    Table 65. Novartis Revenue in Dementia and Alzheimer’s Disease Treatment Business (2016-2021) & (US$ Million)
    Table 66. Novartis Recent Development
    Table 67. Pfizer, Inc. Company Details
    Table 68. Pfizer, Inc. Business Overview
    Table 69. Pfizer, Inc. Dementia and Alzheimer’s Disease Treatment Product
    Table 70. Pfizer, Inc. Revenue in Dementia and Alzheimer’s Disease Treatment Business (2016-2021) & (US$ Million)
    Table 71. Pfizer, Inc. Recent Development
    Table 72. AbbVie Inc. Company Details
    Table 73. AbbVie Inc. Business Overview
    Table 74. AbbVie Inc. Dementia and Alzheimer’s Disease Treatment Product
    Table 75. AbbVie Inc. Revenue in Dementia and Alzheimer’s Disease Treatment Business (2016-2021) & (US$ Million)
    Table 76. AbbVie Inc. Recent Development
    Table 77. Allergan plc Company Details
    Table 78. Allergan plc Business Overview
    Table 79. Allergan plc Dementia and Alzheimer’s Disease Treatment Product
    Table 80. Allergan plc Revenue in Dementia and Alzheimer’s Disease Treatment Business (2016-2021) & (US$ Million)
    Table 81. Allergan plc Recent Development
    Table 82. Eli Lilly and Company Company Details
    Table 83. Eli Lilly and Company Business Overview
    Table 84. Eli Lilly and Company Dementia and Alzheimer’s Disease Treatment Product
    Table 85. Eli Lilly and Company Revenue in Dementia and Alzheimer’s Disease Treatment Business (2016-2021) & (US$ Million)
    Table 86. Eli Lilly and Company Recent Development
    Table 87. F. Hoffmann-La Roche Ltd. Company Details
    Table 88. F. Hoffmann-La Roche Ltd. Business Overview
    Table 89. F. Hoffmann-La Roche Ltd. Dementia and Alzheimer’s Disease Treatment Product
    Table 90. F. Hoffmann-La Roche Ltd. Revenue in Dementia and Alzheimer’s Disease Treatment Business (2016-2021) & (US$ Million)
    Table 91. F. Hoffmann-La Roche Ltd. Recent Development
    Table 92. AstraZeneca Company Details
    Table 93. AstraZeneca Business Overview
    Table 94. AstraZeneca Dementia and Alzheimer’s Disease Treatment Product
    Table 95. AstraZeneca Revenue in Dementia and Alzheimer’s Disease Treatment Business (2016-2021) & (US$ Million)
    Table 96. AstraZeneca Recent Development
    Table 97. Biogen Company Details
    Table 98. Biogen Business Overview
    Table 99. Biogen Revenue in Dementia and Alzheimer’s Disease Treatment Business (2016-2021) & (US$ Million)
    Table 100. Biogen Recent Development
    Table 101. Eisai Co., Ltd. Company Details
    Table 102. Eisai Co., Ltd. Business Overview
    Table 103. Eisai Co., Ltd. Dementia and Alzheimer’s Disease Treatment Product
    Table 104. Eisai Co., Ltd. Revenue in Dementia and Alzheimer’s Disease Treatment Business (2016-2021) & (US$ Million)
    Table 105. Eisai Co., Ltd. Recent Development
    Table 106. INmuneBIO Company Details
    Table 107. INmuneBIO Business Overview
    Table 108. INmuneBIO Dementia and Alzheimer’s Disease Treatment Product
    Table 109. INmuneBIO Revenue in Dementia and Alzheimer’s Disease Treatment Business (2016-2021) & (US$ Million)
    Table 110. INmuneBIO Recent Development
    Table 111. Research Programs/Design for This Report
    Table 112. Key Data Information from Secondary Sources
    Table 113. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Dementia and Alzheimer’s Disease Treatment Market Share by Type: 2020 VS 2027
    Figure 2. Cholinesterase Inhibitors Features
    Figure 3. Memantine Features
    Figure 4. Combination Drugs Features
    Figure 5. Global Dementia and Alzheimer’s Disease Treatment Market Share by Application: 2020 VS 2027
    Figure 6. Hospital Case Studies
    Figure 7. Clinic Case Studies
    Figure 8. Dementia and Alzheimer’s Disease Treatment Report Years Considered
    Figure 9. Global Dementia and Alzheimer’s Disease Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 10. Global Dementia and Alzheimer’s Disease Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global Dementia and Alzheimer’s Disease Treatment Market Share by Regions: 2020 VS 2027
    Figure 12. Global Dementia and Alzheimer’s Disease Treatment Market Share by Regions (2022-2027)
    Figure 13. Global Dementia and Alzheimer’s Disease Treatment Market Share by Players in 2020
    Figure 14. Global Top Dementia and Alzheimer’s Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dementia and Alzheimer’s Disease Treatment as of 2020
    Figure 15. The Top 10 and 5 Players Market Share by Dementia and Alzheimer’s Disease Treatment Revenue in 2020
    Figure 16. Global Dementia and Alzheimer’s Disease Treatment Revenue Market Share by Type (2016-2021)
    Figure 17. Global Dementia and Alzheimer’s Disease Treatment Revenue Market Share by Type (2022-2027)
    Figure 18. North America Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 19. North America Dementia and Alzheimer’s Disease Treatment Market Share by Type (2016-2027)
    Figure 20. North America Dementia and Alzheimer’s Disease Treatment Market Share by Application (2016-2027)
    Figure 21. North America Dementia and Alzheimer’s Disease Treatment Market Share by Country (2016-2027)
    Figure 22. United States Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. Canada Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Europe Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Dementia and Alzheimer’s Disease Treatment Market Share by Type (2016-2027)
    Figure 26. Europe Dementia and Alzheimer’s Disease Treatment Market Share by Application (2016-2027)
    Figure 27. Europe Dementia and Alzheimer’s Disease Treatment Market Share by Country (2016-2027)
    Figure 28. Germany Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. France Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. U.K. Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Italy Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Russia Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Nordic Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Share by Type (2016-2027)
    Figure 36. Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Share by Application (2016-2027)
    Figure 37. Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Share by Region (2016-2027)
    Figure 38. China Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Japan Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. South Korea Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Southeast Asia Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. India Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Australia Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Latin America Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Dementia and Alzheimer’s Disease Treatment Market Share by Type (2016-2027)
    Figure 46. Latin America Dementia and Alzheimer’s Disease Treatment Market Share by Application (2016-2027)
    Figure 47. Latin America Dementia and Alzheimer’s Disease Treatment Market Share by Country (2016-2027)
    Figure 48. Mexico Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Brazil Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Share by Type (2016-2027)
    Figure 52. Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Share by Application (2016-2027)
    Figure 53. Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Share by Country (2016-2027)
    Figure 54. Turkey Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Saudi Arabia Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. UAE Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Novartis Revenue Growth Rate in Dementia and Alzheimer’s Disease Treatment Business (2016-2021)
    Figure 58. Pfizer, Inc. Revenue Growth Rate in Dementia and Alzheimer’s Disease Treatment Business (2016-2021)
    Figure 59. AbbVie Inc. Revenue Growth Rate in Dementia and Alzheimer’s Disease Treatment Business (2016-2021)
    Figure 60. Allergan plc Revenue Growth Rate in Dementia and Alzheimer’s Disease Treatment Business (2016-2021)
    Figure 61. Eli Lilly and Company Revenue Growth Rate in Dementia and Alzheimer’s Disease Treatment Business (2016-2021)
    Figure 62. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Dementia and Alzheimer’s Disease Treatment Business (2016-2021)
    Figure 63. AstraZeneca Revenue Growth Rate in Dementia and Alzheimer’s Disease Treatment Business (2016-2021)
    Figure 64. Biogen Revenue Growth Rate in Dementia and Alzheimer’s Disease Treatment Business (2016-2021)
    Figure 65. Eisai Co., Ltd. Revenue Growth Rate in Dementia and Alzheimer’s Disease Treatment Business (2016-2021)
    Figure 66. INmuneBIO Revenue Growth Rate in Dementia and Alzheimer’s Disease Treatment Business (2016-2021)
    Figure 67. Bottom-up and Top-down Approaches for This Report
    Figure 68. Data Triangulation
    Figure 69. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Novartis
Pfizer, Inc.
AbbVie Inc.
Allergan plc
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
AstraZeneca
Biogen
Eisai Co., Ltd.
INmuneBIO
Frequently Asked Questions
Dementia and Alzheimer’s Disease Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Dementia and Alzheimer’s Disease Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Dementia and Alzheimer’s Disease Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

HIV Self-Testing

The growth of the global HIV self-testing market is thriving on the back of growing prevalence of ... Read More